Renexxion Ireland Revenue

Pharmaceutical Manufacturing • Roscrea, Co Offaly, Ireland • 11-20 Employees

Renexxion Ireland revenue & valuation

Annual revenue	$941,105
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$3,100,000
Total funding	No funding

Key Contacts at Renexxion Ireland

Ken Kengatharan

Board Director And Cbo [Renexxion, Inc., Holdco Of Renexxion Ireland, Ltd.]

Richard Hendrick

Non Executive Director

Peter Milner

Chief Executive Officer And Chairman

Company overview

Headquarters	Dungar House, Roscrea, Co. Tipperary E53 N220 , IE
Phone number	+16509249895
Websites	rnexltd.ie renexxion.com
NAICS	3254
SIC	283
Keywords	Drug Development And Gastrointestinal
Employees	11-20
Socials

Renexxion Ireland Email Formats

Renexxion Ireland uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@rnexltd.ie), used 62.5% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@rnexltd.ie	62.5%
{first name}.{last name}	john.doe@rnexltd.ie	37.5%

About Renexxion Ireland

Renexxion Ireland Innovation There is a large unmet medical need for patients with disorders of gastrointestinal motility. Naronapride, a late-development stage, Phase-3 ready, oral gastro-prokinetic, 5-HT4 agonist has shown efficacy in a wide range of these disorders. It is estimated that at least 16% of people worldwide suffer from GI-related disorders. Currently approved therapies do not completely address this high therapeutic need. In some cases, there are no approved therapies. Naronapride has the potential to address the major GI indications associated with dysmotility including chronic idiopathic constipation (CIC), irritable bowel syndrome - constipation type (IBSc), functional dyspepsia (FD), gastroparesis (GP), and gastro-esophageal reflux disease (GERD), in particular PPI-resistant GERD where chronic oral treatments are required. Naronapride may also address unmet therapeutic needs in smaller GI-related indications, both chronic and acute. These include Enteral Feeding Intolerance (EFI), acute GP, short bowel syndrome (SBS), and post-operative ileus (POI).

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

C-Suite

Director

Employees by Department

Renexxion Ireland has 4 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Renexxion Ireland's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2017-02-01	1	N/A

Funding Insights

Number of funding rounds

Renexxion Ireland Tech Stack

Discover the technologies and tools that power Renexxion Ireland's digital infrastructure, from frameworks to analytics platforms.

MediaElement.js

Video players

reCAPTCHA

Security

Cloudflare Bot Management

Security

Vimeo

Video players

Cloudflare

CDN

jQuery

JavaScript libraries

Weebly

CMS

Hammer.js

JavaScript libraries

PHP

Programming languages

Google Analytics

Analytics

Google Tag Manager

Tag managers

Mustache

JavaScript frameworks

Frequently asked questions

Renexxion Ireland is located in Roscrea, Co Offaly, IE.

You can reach Renexxion Ireland at +16509249895.

Renexxion Ireland generates an estimated annual revenue of $941,105. This revenue figure reflects the company's market position and business performance in its industry.

Renexxion Ireland has an estimated valuation of $3,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Renexxion Ireland has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.